National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 6028 [2016-02050]

Agencies

• DEPARTMENT OF HEALTH AND HUMAN SERVICES
• National Institutes of Health

[Federal Register Volume 81, Number 23 (Thursday, February 4, 2016)]
[Notices]
[Page 6028]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-02050]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Allergy, Immunology, and Transplantation 
Research Committee.
    Date: February 24-25, 2016.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 
Montgomery County Conference Center Facility, White Oak B Room, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: James T. Snyder, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities/Room 3G31B, National Institutes of Health, NIAID, 5601 
Fishers Lane MSC 9834, Bethesda, MD 20892-9834, (240) 669-5060, 
james.snyder@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)


    Dated: January 29, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-02050 Filed 2-3-16; 8:45 am]
 BILLING CODE 4140-01-P